Viewing Study NCT01542918


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-03-01 @ 6:01 AM
Study NCT ID: NCT01542918
Status: COMPLETED
Last Update Posted: 2020-08-11
First Post: 2012-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma
Sponsor: James Rubenstein
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent/Refractory CNS View
None Intraocular Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recurrent View
None Refractory View
None CNS View
None Intraocular View
None Lymphoma View